Mark P. Ward
Impact in
- Internal Medicine top 10%
- Venous Thromboembolism Diagnosis and Management
-
- Cancer Genomics and Diagnostics
- Cancer-related molecular mechanisms research
- Cancer, Hypoxia, and Metabolism
Papers in
-
- Cancer-related molecular mechanisms research 4
- Cancer Genomics and Diagnostics 3
- MicroRNA in disease regulation 2
-
- Circular RNAs in diseases 3
- RNA modifications and cancer 2
- Co-authors
- Sharon O’Toole (15 shared papers)John O’Leary (15 shared papers)Lucy Norris (9 shared papers)Doug A. Brooks (7 shared papers)Stavros Selemidis (6 shared papers)Mark Bates (4 shared papers)Bashir M. Mohamed (5 shared papers)Cara Martin (6 shared papers)
- Journals
- International Journal of Molecular Sciences (3 papers)Thrombosis Research (3 papers)Cancers (2 papers)Molecular Cancer (1 paper)Oncotarget (1 paper)
- Partner nations
- IrelandAustraliaUnited States
In The Last Decade
Mark P. Ward
24 papers receiving 350 citations
Peers
Comparison fields: 5 of 60
- Internal Medicine 26
- Cancer Research 91
- Oncology 123
- Hematology 24
- Biotechnology 18
Countries citing papers authored by Mark P. Ward
This map shows the geographic impact of Mark P. Ward's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark P. Ward with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark P. Ward more than expected).
Fields of papers citing papers by Mark P. Ward
This network shows the impact of papers produced by Mark P. Ward. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark P. Ward. The network helps show where Mark P. Ward may publish in the future.
Co-authors
The 25 scholars most cited alongside Mark P. Ward, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 26 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 103 | |
| 2 | Association of the SS genotype of the L-myc gene and loss of 18q sequences with a worse clinical prognosis in colorectal cancers. | 1994 | 27 |
| 3 | 2023 | 25 | |
| 4 | 2020 | 21 | |
| 5 | 2018 | 19 | |
| 6 | 2017 | 17 | |
| 7 | 2021 | 17 | |
| 8 | 2020 | 15 | |
| 9 | 2018 | 15 | |
| 10 | 2023 | 13 | |
| 11 | 2021 | 13 | |
| 12 | 2021 | 10 | |
| 13 | 2024 | 9 | |
| 14 | 2020 | 8 | |
| 15 | 2021 | 8 | |
| 16 | 2024 | 7 | |
| 17 | 2023 | 7 | |
| 18 | 2025 | 7 | |
| 19 | 2022 | 5 | |
| 20 | 2021 | 3 |
About Mark P. Ward
Mark P. Ward is a scholar working on Cancer Research, Molecular Biology, Oncology, Internal Medicine and Public Health, Environmental and Occupational Health, having authored 26 papers that have together received 354 indexed citations. Recurring topics across this work include Cancer Cells and Metastasis (5 papers), Cancer-related molecular mechanisms research (4 papers), Cancer Genomics and Diagnostics (3 papers), Circular RNAs in diseases (3 papers), Cancer Immunotherapy and Biomarkers (3 papers), Venous Thromboembolism Diagnosis and Management (2 papers), MicroRNA in disease regulation (2 papers) and RNA modifications and cancer (2 papers). The work is most often cited by research in Internal Medicine (26 citations), Cancer Research (91 citations), Oncology (123 citations), Hematology (24 citations) and Biotechnology (18 citations). Mark P. Ward has collaborated with scholars based in Ireland, Australia and United States. Frequent co-authors include Sharon O’Toole, John O’Leary, Lucy Norris, Doug A. Brooks, Stavros Selemidis, Mark Bates, Bashir M. Mohamed, Cara Martin, Robert D. Brooks and Paul Spiers. Their work appears in journals such as International Journal of Molecular Sciences, Thrombosis Research, Cancers, Molecular Cancer and Oncotarget.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.